Cwc Advisors, Llc. Bristol Myers Squibb CO Transaction History
Cwc Advisors, Llc.
- $194 Billion
- Q2 2025
A detailed history of Cwc Advisors, Llc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cwc Advisors, Llc. holds 5,106 shares of BMY stock, worth $235,641. This represents 0.12% of its overall portfolio holdings.
Number of Shares
5,106
Previous 5,100
0.12%
Holding current value
$235,641
Previous $311 Million
24.01%
% of portfolio
0.12%
Previous 0.18%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,675Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$9 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.32 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.99 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.37 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.27 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98.1B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...